New Phone Number for the Maternal Mental Health Hotline: 1-833-TLC-MAMA
This hotline will offer a range of support, including brief interventions, referrals to both community-based and telehealth providers as needed.
This hotline will offer a range of support, including brief interventions, referrals to both community-based and telehealth providers as needed.
Imagine if we could use machine learning to enhance the care we deliver, analyzing a larger body of patient-specific factors in order to make more reliable predictions of risk for perinatal mood and anxiety disorders.
Addressing sleep problems may be an important component of suicide prevention efforts, as improving sleep quality and duration may help to reduce the risk of suicide in perinatal population.
This preliminary study suggests that web-based interventions with coaching are feasible, acceptable, and potentially effective treatment options for women with mild to moderate postpartum depression and/or anxiety.
In this randomized controlled trial, a CBT-based workshop for women with PPD led to clinically meaningful reductions in depression and anxiety.
In women with postpartum depression, zuranolone was associated with concurrent improvements in depression, anxiety symptoms, and insomnia beginning at day 3.
Evidence suggests that sleep disturbance during pregnancy is associated with higher risk of perinatal depression, especially during the third trimester.
Should we also be assessing women’s partners to determine if they have postpartum depression?
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on the new recommendation by the Canadian Task Force on Preventative Health Care which advises against systematic questionnaires for PPD screening with Ob.Gyn News on January 20, 2023.
A New Drug Application for zuranolone awaits FDA approval for the treatment of major depressive disorder (MDD) and postpartum depression (PPD).